Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2440]

FDA approves nivolumab plus ipilimumab combination for intermediate or poor-risk advanced renal cell carcinoma

FDA approves nivolumab plus ipilimumab combination for intermediate or poor-risk advanced renal cell carcinoma

AACR 2018: When prostate cancer reaches bone, bone cells may drive overall growth of the disease

AACR 2018: When prostate cancer reaches bone, bone cells may drive overall growth of the disease

Scientists uncover 80 potential lines of attack against prostate cancer

Scientists uncover 80 potential lines of attack against prostate cancer

AACR 2018: Effect of prostate cancer gene can go either way

AACR 2018: Effect of prostate cancer gene can go either way

'Killer' kidney cancers identified by studying their evolution

'Killer' kidney cancers identified by studying their evolution

Simultaneous chemo and immunotherapy may be better for some with metastatic bladder cancer

Simultaneous chemo and immunotherapy may be better for some with metastatic bladder cancer

Last Month in Oncology with Dr. Bishal Gyawali: March 2018

Last Month in Oncology with Dr. Bishal Gyawali: March 2018

Contrast-enhanced subharmonic imaging detects prostate cancers not identified by MRI

Contrast-enhanced subharmonic imaging detects prostate cancers not identified by MRI

Simultaneous chemo and immunotherapy may be better for some with metastatic bladder cancer

Simultaneous chemo and immunotherapy may be better for some with metastatic bladder cancer

Organoids created from patients' bladder cancers could guide treatment

Organoids created from patients' bladder cancers could guide treatment

More from ecancer